The role of helicobacter pylori as a risk factor for hyperemesis gravidarum and its management
العناوين الأخرى
دور ميكروب الهيلكوباكتر بايلوري في حدوث حالات القيء المتكرر أثناء الحمل و علاجه
المؤلفون المشاركون
Kassab, Farid A.
Farhan, Abd al-Sattar
al-Said, Usamah
Said, Samih
Hablas, Wail Rifat
المصدر
Reproductive Health and Population Sciences Journal
العدد
المجلد 2016، العدد 41 (31 يناير/كانون الثاني 2016)، ص ص. 55-70، 16ص.
الناشر
جامعة الأزهر المركز الدولي الإسلامي للدراسات و البحوث السكانية
تاريخ النشر
2016-01-31
دولة النشر
مصر
عدد الصفحات
16
التخصصات الرئيسية
الملخص EN
Background: Hyperemesis gravidarum is a disease of severe nausea, vomiting and anorexia associated with early pregnancy leading to dehydration and weight loss which occurs in approximately 0.3-2% of pregnancies.
The principal condition to diagnose hyperemesis gravidarum is the presence of three or more vomiting episodes during the day, weight loss of over 5% and ketonuria.
The problem is generally time limited with onset about the fifth week after the last menstrual period, a peak at about 8-12 weeks, and resolution by 16-18 weeks for most women.
The factors associated with hyperemesis are primarily medical and fetal factors.
In the last years, association between Helicobacter Pylori and hyperemesis gravidarum has been found and serologically positive H.
Pylori infection has been demonstrated in the hyperemesis patients.
Objective: To determine the role of Helicobacter Pylori as a risk factor of Hyperemesis Gravidarum, the role of adding non teratogenic regimen for its treatment, the role of Ondansetrone for treatment of resistant cases.
Methods: The study include 80 women, Group (1) 40 women with Hyperemesis Gravidarum and Group (2) 40 women with usual antenatal care.
Serum H Pylori Ig G titre was measured for detection of incidence of seropositivety in both groups.
the efficacy of Helicobacter treatment was determined in seropositive cases.
The effect of Ondansetrone treatment was detected in resistant cases in both groups.
Results: Regarding H Pylori seropositivety there was significant difference between study group 27 (67,5%) and control groups 14 (35%).
Regarding the efficacy of H Pylori treatment in seropositive cases that resist the usual treatment there was
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Kassab, Farid A.& Farhan, Abd al-Sattar& al-Said, Usamah& Said, Samih& Hablas, Wail Rifat. 2016. The role of helicobacter pylori as a risk factor for hyperemesis gravidarum and its management. Reproductive Health and Population Sciences Journal،Vol. 2016, no. 41, pp.55-70.
https://search.emarefa.net/detail/BIM-747355
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Kassab, Farid A.…[et al.]. The role of helicobacter pylori as a risk factor for hyperemesis gravidarum and its management. Reproductive Health and Population Sciences Journal No. 41 (Jan. 2016), pp.55-70.
https://search.emarefa.net/detail/BIM-747355
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Kassab, Farid A.& Farhan, Abd al-Sattar& al-Said, Usamah& Said, Samih& Hablas, Wail Rifat. The role of helicobacter pylori as a risk factor for hyperemesis gravidarum and its management. Reproductive Health and Population Sciences Journal. 2016. Vol. 2016, no. 41, pp.55-70.
https://search.emarefa.net/detail/BIM-747355
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 67-69
رقم السجل
BIM-747355
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر